Natus Medical Incorporated(NTUS)

Sector:

Healthcare

Description:

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

Current Price

$32.96

RSI

73.67

Market Capitalization:

1.1B

Beta:

0.227

Analyst Target Price:

$ 36

Economiic Fair Price:


August 04, 2022
May 06, 2022
Q1
N/A
N/A
N/A
N/A
N/A
84.3M
10.2M
0.38
2.65 %
14.15
0.0302

15.04 %
71.47 %
40.15 %
4.23 %
17.81 %
-67.32 %

$ 473.4M
13.89 %
$ 415.7M
-16.05 %
$ 495.2M
-6.73 %
$ 530.9M
5.97 %
$ 501M
31.18 %
$ 381.9M

$ 60.4M
133.86 %
$ 25.8M
-52.82 %
$ 54.7M
123.53 %
$ 24.5M
56.32 %
$ 15.7M
-77.40 %
$ 69.3M

$ 19.4M
187.72 %
$ -22.1M
-3.80 %
$ -21.3M
34.11 %
$ -32.3M
-726.41 %
$ 5.2M
-90.62 %
$ 54.9M

News

Press Releases

Notable Dates